News
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money 18 May 2022
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes ...
-
Improving education with videos and humour 10 May 2022
To better prepare students for lab sessions, a team from the BSc-programme Bio-Pharmaceutical Sciences (BFW) creates interactive videos. These videos ...
-
Researchers tackle antibiotic-resistant bacteria 06 May 2022
When a bacterium becomes more resistant to one antibiotic, it sometimes becomes more sensitive to another. To better understand this interaction, rese...
-
Royal honour for emeritus professor Ad IJzerman 26 April 2022
Ad IJzerman, Emeritus Professor of Pharmacochemistry, was made a Knight of the Order of the Lion of the Netherlands on 26 April. He was presented with...
-
National Growth Fund invests many millions in faster and more sustainable (cancer) drug development 14 April 2022
On 14 April, the National Growth Fund awarded million euros in grants to two consortia in which Leiden's science faculty is involved. Pharma-NL will r...
-
Better treatment of skin diseases thanks to NWA grant of 11.7 million euros 31 March 2022
Patients with skin diseases such as eczema and psoriasis, sometimes spend a lifetime searching for the right medication. To help these patients faster...
-
ERC grant for Sebastian Pomplun to precisely influence gene expression 30 March 2022
In order to stop a whole range of diseases or disorders at their source, you would have to be able to switch certain genes on or off. Sebastian Pomplu...
-
Drugs with fewer side effects through a collaboration between LACDR and PTS 30 March 2022
LACDR, the Leiden Institute for Drug Research, developed better tolerated excipients to prevent adverse effects related to the surface of nanosized dr...
-
Combating antibiotic resistance together 24 March 2022
Antibiotic resistance is a common problem among patients. The European Project TIPAT trains pharmacologists, microbiologists and immunologists of six ...
-
Leiden researchers join forces against tuberculosis 24 March 2022
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it ...
-
Awarded research project Next Generation ImmunoDermatology: Towards Biomarker-driven Dermatology practice in the Netherlands 23 March 2022
The Dutch Research Council (NWO) has, within the framework of Research along Routes by Consortia (NWA-ORC), awarded the research project Next Generati...
-
NWA grants for interdisciplinary consortia 21 March 2022
Several consortia in which Leiden University is involved have been awarded Dutch Research Agenda funding. Leiden is the coordinator of five of these c...
-
University of Geneva has joined ULLA consortium to become its 10th member 11 March 2022
ULLA, the European University Consortium for Pharmaceutical Sciences, is welcoming our tenth member: the School of Pharmaceutical Sciences of the Univ...
-
Is a cancer pill a matter of time? 21 February 2022
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put t...
-
MasterMinds Challenge named best educational innovation 16 February 2022
The Master of Medicine at Leiden University Medical Center (LUMC) has won the national biennial award for best educational innovation in medical teach...